MSD Wellcome R&D centre in IndiaIllustrative image – not actual.

MSD India, a drug company and fully-owned subsidiary of US based Merck & Co, plans to set up a research and development (R&D) centre in India in JV with UK based Wellcome Laboratories.

The centre - MSD Wellcome Trust Hilleman Laboratories - will be a 50:50 JV and come up with a total investment of $130 million (approx Rs 586 crore). Of this, MSD is expected to pump in $65 million (approx Rs 292.5 crore). The centre will develop affordable vaccines for the developing countries.

← All latest storiesBack to top →